These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8628138)

  • 21. Comparison of serologic responses between Kaposi's sarcoma-positive and -negative men who were seropositive for both human herpesvirus 8 and human immunodeficiency virus.
    Inoue N; Spira T; Lam L; Corchero JL; Luo W
    J Med Virol; 2004 Oct; 74(2):202-6. PubMed ID: 15332267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Restoring HIV-specific immunity.
    James JS
    AIDS Treat News; 1999 Feb; (No 312):2-6. PubMed ID: 11366200
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Managing HIV. Part 3. Mechanisms of disease. 3.2 How HIV produces immune deficiency.
    Ffrench R; Stewart GJ; Penny R; Levy JA
    Med J Aust; 1996 Feb; 164(3):166-71. PubMed ID: 8628137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A killer mimotope with therapeutic activity against AIDS-related opportunistic micro-organisms inhibits ex-vivo HIV-1 replication.
    Casoli C; Pilotti E; Perno CF; Balestra E; Polverini E; Cassone A; Conti S; Magliani W; Polonelli L
    AIDS; 2006 Apr; 20(7):975-80. PubMed ID: 16603848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical features of HIV disease in developing countries.
    Grant A
    Lepr Rev; 2002 Jun; 73(2):197-205. PubMed ID: 12192976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women.
    Viscidi RP; Ahdieh-Grant L; Clayman B; Fox K; Massad LS; Cu-Uvin S; Shah KV; Anastos KM; Squires KE; Duerr A; Jamieson DJ; Burk RD; Klein RS; Minkoff H; Palefsky J; Strickler H; Schuman P; Piessens E; Miotti P
    J Infect Dis; 2003 Jan; 187(2):194-205. PubMed ID: 12552444
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship of in vivo and ex vivo levels of TH1 and TH2 cytokines with viremia in HAART patients with and without opportunistic infections.
    Sindhu S; Toma E; Cordeiro P; Ahmad R; Morisset R; Menezes J
    J Med Virol; 2006 Apr; 78(4):431-9. PubMed ID: 16482539
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between clinical conditions and CD4 counts in HIV-infected persons in Pune, Maharashtra, India.
    Ghate MV; Mehendale SM; Mahajan BA; Yadav R; Brahme RG; Divekar AD; Paranjape RS
    Natl Med J India; 2000; 13(4):183-7. PubMed ID: 11002684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Moods brighten as statistics lighten.
    Gilden D
    GMHC Treat Issues; 1998 Mar; 12(3):1-5. PubMed ID: 11365390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Leishmaniases and HIV/AIDS co-infections: review of common features and management experiences.
    Ali A
    Ethiop Med J; 2002 Apr; 40 Suppl 1():37-49. PubMed ID: 12802830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural history of HIV illness.
    Lal S; Sengupta D
    J Indian Med Assoc; 1993 Dec; 91(12):319-20. PubMed ID: 7908922
    [No Abstract]   [Full Text] [Related]  

  • 32. [HIV replication and pulmonary opportunistic infections].
    Israël-Biet D; Cadranel J
    Rev Mal Respir; 1998 Jun; 15(3):247-54. PubMed ID: 9677632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Managing some of the common opportunistic infections in advanced HIV infection.
    Brandon WR
    J La State Med Soc; 1992 Oct; 144(10):443-4. PubMed ID: 1474294
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of multiple herpesvirus infections on the progression of HIV disease in a cohort of HIV seroconverters.
    Suligoi B; Dorrucci M; Uccella I; Andreoni M; Rezza G;
    J Med Virol; 2003 Feb; 69(2):182-7. PubMed ID: 12683405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Viral participation in cellular and microenvironmental transformation and amplification towards malignancy in AIDS patients.
    Agius LM
    Med Hypotheses; 2004; 62(4):593-9. PubMed ID: 15050113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leprosy reversal reaction as immune reconstitution inflammatory syndrome in patients with AIDS.
    Batista MD; Porro AM; Maeda SM; Gomes EE; Yoshioka MC; Enokihara MM; Tomimori J
    Clin Infect Dis; 2008 Mar; 46(6):e56-60. PubMed ID: 18269334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multiple opportunistic AIDS-associated disorders strictly related to immunodeficiency levels, in a girl with congenital HIV infection.
    Manfredi R; Calza L; Chiodo F
    Int J STD AIDS; 2003 Sep; 14(9):638-9. PubMed ID: 14511504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
    Bronke C; Palmer NM; Jansen CA; Westerlaken GH; Polstra AM; Reiss P; Bakker M; Miedema F; Tesselaar K; van Baarle D
    J Infect Dis; 2005 Mar; 191(6):873-80. PubMed ID: 15717261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inconsistent reconstitution of cytomegalovirus-specific cell-mediated immunity in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy.
    Weinberg A; Wohl DA; Barrett RJ; van der Horst C
    J Infect Dis; 2001 Sep; 184(6):707-12. PubMed ID: 11517431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ocular manifestations of HIV infection.
    Jabs DA
    Trans Am Ophthalmol Soc; 1995; 93():623-83. PubMed ID: 8719695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.